Natixis Has $17.29 Million Position in Colgate-Palmolive (NYSE:CL)

Natixis lifted its holdings in Colgate-Palmolive (NYSE:CL - Free Report) by 25.7% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 190,167 shares of the company's stock after purchasing an additional 38,829 shares during the quarter. Natixis' holdings in Colgate-Palmolive were worth $17,288,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Kohmann Bosshard Financial Services LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $27,000. Union Bancaire Privee UBP SA acquired a new position in shares of Colgate-Palmolive during the 4th quarter worth approximately $32,000. Briaud Financial Planning Inc bought a new stake in Colgate-Palmolive in the 4th quarter valued at $32,000. Finally, Wintrust Investments LLC acquired a new stake in Colgate-Palmolive during the 4th quarter valued at $33,000. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

NYSE CL traded up $1.53 during trading on Friday, hitting $94.23. 5,658,259 shares of the company's stock were exchanged, compared to its average volume of 4,653,764. The company has a market cap of $76.43 billion, a PE ratio of 26.74, a P/E/G ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock's 50 day moving average price is $91.92 and its two-hundred day moving average price is $92.27.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, beating analysts' consensus estimates of $0.88 by $0.03. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.92 billion. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the business posted $0.86 earnings per share. Research analysts expect that Colgate-Palmolive will post 3.75 EPS for the current year.

Colgate-Palmolive announced that its board has authorized a share buyback program on Thursday, March 20th that allows the company to buyback $5.00 billion in outstanding shares. This buyback authorization allows the company to purchase up to 6.8% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board of directors believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Stockholders of record on Thursday, April 17th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This represents a $2.08 annualized dividend and a dividend yield of 2.21%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is currently 59.09%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CL. Stifel Nicolaus dropped their price objective on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating on the stock in a research report on Monday, February 3rd. Raymond James restated an "outperform" rating and set a $105.00 price objective (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. Piper Sandler reduced their price target on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating for the company in a research note on Monday, March 31st. Finally, JPMorgan Chase & Co. lowered their price objective on Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Friday, April 11th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, Colgate-Palmolive has an average rating of "Hold" and a consensus price target of $102.17.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.